ArticlePLoS computational biology2026
CPP2Vec: A representation learning approach for cell-penetrating peptides prediction.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCell-penetrating peptides (CPPs) facilitate the delivery of a variety of therapeutic molecules across the plasma membrane, from small chemical substances to nucleic acid-based macromolecules, such as antisense oligonucleotides (ASOs). Among neutral ASOs, peptide nucleic acids (PNAs) and phosphorodiamidate morpholino oligomers (PMOs) have been extensively studied as potential medical treatments for Duchenne Muscular Dystrophy (DMD), a severe genetic disease that causes muscle degeneration progressively. Over the last few decades, many in silico methods have emerged to detect novel CPPs, counterbalancing the cost of wet-lab experiments.
resultsIn this study, we propose CPP2Vec, a Word2Vec-based CPP prediction method, where the Word2Vec technique is used to represent amino acid sequences of peptides. To address the limited sequence diversity, sparse biological grounding, and the still poorly understood mechanisms underlying CPPs uptake, we constructed CPP2Vec-GenSet, a hybrid dataset that integrates computationally generated peptides with experimentally curated CPPs. This combined resource provides a robust training foundation that supports reliable representation learning and enhances cross-task model performance. Using this framework, we developed three task-specific supervised machine learning models for CPP-Classification, Uptake-Efficiency and PMO-Delivery. The first two models were designed to determine if an unseen peptide is a CPP and to predict its uptake efficiency, respectively, while the PMO-Delivery model predicts whether a peptide could enhance the cellular delivery of a PMO-complex compared to its naked version. Furthermore, we explored an alternative approach using pre-trained protein-based Large Language Models (LLMs) - ProtT5, ProtBERT, and ESM-2 - to generate the embeddings, resulting in three task-specific models, namely CPP2LLM. Benchmarking against state-of-the-art CPP prediction tools demonstrates that CPP2Vec achieves robust predictive performance and generalization across tasks, while maintaining exceptional computational efficiency.
conclusionIn this research, we present a Machine Learning (ML)-based tool that introduces the use of the Word2Vec technique in the field of CPPs prediction. Notably, CPP2Vec automatically learns informative peptide representations directly from sequence data, generalizes reliably across multiple tasks, and achieves high predictive performance with minimal computational resources, providing a reproducible and practical in silico tool to support the early-stage identification and prioritization of CPPs with potential therapeutic relevance. CPP2Vec is available for use at: https://github.com/SSvolou/CPP2Vec.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.